Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Dec 29;24(1):704.
doi: 10.1186/s13054-020-03336-0.

Plasma levels of the active form of suPAR are associated with COVID-19 severity

Mingxiang Huang  1 , Linlin Li  2 , Jianshan Shen  1 , Yao Wang  1 , Rui Wang  1 , Cai Yuan  3 , Mingdong Huang  4 , Longguang Jiang  5   6
Affiliations
Comment

Plasma levels of the active form of suPAR are associated with COVID-19 severity

Mingxiang Huang et al. Crit Care. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Level of plasma active suPAR in different classifications. a Active suPAR level in COVID-19 patients and asymptomatic carriers, compared with active suPAR level in healthy controls. b Level of active suPAR between three different COVID-19 classifications including moderate, severe, and critical
See this image and copyright information in PMC

Comment on

References

    1. Rovina N, Akinosoglou K, Eugen-Olsen J, Hayek S, Reiser J, Giamarellos-Bourboulis EJ. Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia. Crit Care. 2020;24(1):187. doi: 10.1186/s13054-020-02897-4. - DOI - PMC - PubMed
    1. Huai Q, Mazar AP, Kuo A, Parry GC, Shaw DE, Callahan J, Li Y, Yuan C, Bian C, Chen L, et al. Structure of human urokinase plasminogen activator in complex with its receptor. Science (New York, NY) 2006;311(5761):656–659. doi: 10.1126/science.1121143. - DOI - PubMed
    1. D’Alonzo D, De Fenza M, Pavone V. COVID-19 and pneumonia: a role for the uPA/uPAR system. Drug Discov Today. 2020 doi: 10.1016/j.drudis.2020.06.013. - DOI - PMC - PubMed
    1. Zhou X, Xu M, Huang H, Mazar A, Iqbal Z, Yuan C, Huang M. An ELISA method detecting the active form of suPAR. Talanta. 2016;160:205–210. doi: 10.1016/j.talanta.2016.07.004. - DOI - PubMed
    1. Resnati M, Pallavicini I, Wang JM, Oppenheim J, Serhan CN, Romano M, Blasi F. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. Proc Natl Acad Sci USA. 2002;2002(99):1359–1364. doi: 10.1073/pnas.022652999. - DOI - PMC - PubMed

Substances